Optimal biased coins for two-arm clinical trials

被引:1
|
作者
Gwise, Thomas E. [1 ]
Hu, Jianhua [2 ]
Hu, Feifang [3 ]
机构
[1] US FDA, Rockville, MD 20857 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Virginia, Dept Stat, Charlottesville, VA 22904 USA
关键词
Adaptive design; D-optimal biased coin; D-A-optimal biased coin; Response adaptive design; Continuous responses; Binary responses;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Atkinson (1982) introduced D-optimal and D-A-optimal biased coin designs to achieve balanced allocation. In this paper, we relax the restrictive assumptions on Atkinson's design so that it can be applied to more realistic situations of heteroscedastic data for two-arm clinic trials. A new class of adaptive biased coin designs is obtained. Further, we derive the asymptotic properties of the proposed allocation procedures, and show that the allocation targets maximizing power via a direct connection to Neyman's allocation scheme. Simulation studies illustrate that the theoretical results are valid and that the proposed design has testing power that is superior to that of the completely randomized allocation scheme.
引用
收藏
页码:125 / 135
页数:11
相关论文
共 50 条
  • [1] Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance
    Shen, Weining
    Ning, Jing
    Yuan, Ying
    [J]. STATISTICS IN MEDICINE, 2015, 34 (13) : 2104 - 2115
  • [2] Generalized optimal design for two-arm, randomized phase II clinical trials with endpoints from the exponential dispersion family
    Jiang, Wei
    Mahnken, Jonathan D.
    He, Jianghua
    Mayo, Matthew S.
    [J]. PHARMACEUTICAL STATISTICS, 2016, 15 (06) : 459 - 470
  • [3] Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach
    Feisst, Manuel
    Krisam, Johannes
    Kieser, Meinhard
    [J]. PHARMACEUTICAL STATISTICS, 2020, 19 (05) : 662 - 678
  • [4] Construction and optimization of gene expression signatures for prediction of survival in two-arm clinical trials
    Theilhaber, Joachim
    Chiron, Marielle
    Dreymann, Jennifer
    Bergstrom, Donald
    Pollard, Jack
    [J]. BMC BIOINFORMATICS, 2020, 21 (01)
  • [5] Construction and optimization of gene expression signatures for prediction of survival in two-arm clinical trials
    Theilhaber, Joachim
    Chiron, Marielle
    Dreymann, Jennifer
    Bergstrom, Donald
    Pollard, Jack
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [6] Construction and optimization of gene expression signatures for prediction of survival in two-arm clinical trials
    Joachim Theilhaber
    Marielle Chiron
    Jennifer Dreymann
    Donald Bergstrom
    Jack Pollard
    [J]. BMC Bioinformatics, 21
  • [7] Optimal Designs for Two-Arm, Phase II Clinical Trial Design with Multiple Constraints
    Mayo, Matthew S.
    Mahnken, Jonathan D.
    Soong, Seng-jaw
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (01) : 106 - 124
  • [8] Bayesian Hypothesis Testing in Two-Arm Trials with Dichotomous Outcomes
    Zaslavsky, Boris G.
    [J]. BIOMETRICS, 2013, 69 (01) : 157 - 163
  • [9] Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints
    Kirchner, Marietta
    Schuepke, Stefanie
    Kieser, Meinhard
    [J]. PHARMACEUTICAL STATISTICS, 2024,
  • [10] Bayesian inference in two-arm trials using relative belief ratios
    Muthukumarana, Saman
    Evans, Michael
    [J]. PHARMACEUTICAL STATISTICS, 2015, 14 (06) : 471 - 478